Skip to main content
SpringerLink
Log in

Various pharmacological options are used to treat nail psoriasis, but choosing the best regimen is difficult

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Edwards F, de Berker D. Nail psoriasis: clinical presentation and best practice recommendations. Drugs 2009; 69(17): 2351–61

    Article  PubMed  CAS  Google Scholar 

  2. Tosti A, Piraccini BM, Cameli N, et al. Calcipotriol in nail psoriasis: a controlled double blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998; 139(4): 655–9

    Article  PubMed  CAS  Google Scholar 

  3. Rigopoulos D, Ioannides D, Prastitis N, et al. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream [letter]. Acta Dermatol Venereol 2002; 82(2): 140

    Article  CAS  Google Scholar 

  4. Tzung TY, Chen CY, Yang CY, et al. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis. Acta Derm Venereol 2008; 88(3): 279–80

    PubMed  Google Scholar 

  5. Scher RK, Stiller M, Zhu YI. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 2001; 68(5): 355–8

    PubMed  CAS  Google Scholar 

  6. Bianchi L, Soda R, Diluvio L, et al. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br J Dermatol 2003; 149(1): 1207–9

    Article  Google Scholar 

  7. Rigopoulos D, Gregoriou S, Katsambas A. Treatment of psoriatic nails with tazarotene cream (0.1%) versus clobetasol propionate 0.05% cream: a double-blind study [letter]. Acta Derm Venereol 2007; 87(2): 167–8

    Article  PubMed  CAS  Google Scholar 

  8. Frederiksson T. Topically applied fluorouracil in the treatment of psoriatic nails. Arch Dermatol 1974; 110(5): 735–6

    Article  Google Scholar 

  9. de Jong EM. Dystrophic psoriatic fingernails treated with 1% fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. Dermatology 1999; 199(4): 313–8

    Article  PubMed  Google Scholar 

  10. Yamamoto T, Katayama I, Nishioka K. Topical anthralin therapy for refractory nail psoriasis. J Dermatol 1998; 25(4): 231–3

    PubMed  CAS  Google Scholar 

  11. Cannavò SP, Guarneri F, Vaccaro M, et al. Treatment of psoriatic nails with topical cyclosporine: a prospective randomized placebo-controlled study. Dermatology 2003; 206(2): 153–6

    Article  PubMed  Google Scholar 

  12. Tosti A, Guerra L, Bardazzi F, et al. Topical ciclosporin in nail psoriasis [letter]. Dermatologica 1990; 180(2): 110–2

    Article  PubMed  CAS  Google Scholar 

  13. de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998 Jan; 138(1): 90–5

    Article  PubMed  Google Scholar 

  14. Gerstein W. Psoriasis and lichen planus of the nails: treatment with triamcinolone. Arch Dermatol 1962 Oct; 86: 419–21

    Article  PubMed  CAS  Google Scholar 

  15. Abell E, Samman PD. Intradermal triamcinolone acetonide for nail dystrophies. Br J Dermatol 1973; 89(2): 191–7

    Article  PubMed  CAS  Google Scholar 

  16. Bleeker JJ. Intralesional triamcinolone acetonide using the Port-o-jet and needle injections in localized dermatoses. Br J Dermatol 1974; 91(1): 97–101

    Article  PubMed  CAS  Google Scholar 

  17. Peachey RDG, Pye RJ, Harman RRM. The treatment of psoriatic nail dystrophy with intradermal steroid injections. Br J Dermatol 1976; 95(1): 75–8

    Article  PubMed  CAS  Google Scholar 

  18. Tosti A, Ricotti C, Romanelli P, et al. Evaluation of the efficacy of acitretin for nail psoriasis. Arch Dermatol 2009; 145(3): 269–71

    Article  PubMed  CAS  Google Scholar 

  19. Mahrle G, Schulze HJ, Farber L, et al. Low-dose short term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995; 32(1): 78–88

    Article  PubMed  CAS  Google Scholar 

  20. Syuto T, Abe M, Ishibuchi H, et al. Successful treatment of psoriatic nails with low-dose cyclosporine administration [letter]. Eur J Dermatol 2007; 17(3): 248–9

    PubMed  Google Scholar 

  21. Rich P, Griffiths CE, Reich K, et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during one year. J Am Acad Dermatol 2008 Feb; 58(2): 224–31

    Article  PubMed  Google Scholar 

  22. Rigopoulos D, Gregoriou S, Stratigos A, et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, non-randomized, open-label study. Br J Dermatol 2008 Aug; 159(2): 453–6

    Article  PubMed  CAS  Google Scholar 

  23. Handfield-Jones SE, Boyle J, Harman RRM. Local PUVA treatment for nail psoriasis. Br J Dermatol 1987; 116(2): 280–1

    Article  PubMed  CAS  Google Scholar 

  24. Marx JL, Scher RK. Response of psoriatic nails to oral photochemotherapy. Arch Dermatol 1980; 116(9): 1023–4

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Various pharmacological options are used to treat nail psoriasis, but choosing the best regimen is difficult. Drugs Ther. Perspect 26, 8–11 (2010). https://doi.org/10.2165/11205420-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11205420-000000000-00000

Search

Navigation